| Gene symbol | GPC3 | Synonyms | DGSX, GTR2-2, MXR7, OCI-5, SDYS, SGB, SGBS, SGBS1 | Type of gene | protein-coding |
| Chromosome | X | Map location | Xq26.2 | dbXrefs | |
| Description | glypican 3 | ||||
| GTO ID | GTC3672 |
| Trial ID | NCT06144385 |
| Disease | Liver Carcinoma |
| Altered gene | GPC3 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | JWCAR204|CAR-GPC3 T cells |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | A Phase 1, Single-arm, Open-label, Dose-escalation Study of JWATM204 as T Cell-targeted Immunotherapy in the Treatment Amongst Subjects With Advanced Hepatocellular Carcinoma |
| Year | 2022 |
| Country | China |
| Company sponsor | Shanghai Ming Ju Biotechnology Co., Ltd. |
| Other ID(s) | JWATM204001 |
| Cohort 1 | |||||||||||||
|
|||||||||||||